ImmPACT Bio Company

ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Technology:
CAR-T
Industry:
Private
Headquarters:
Camarillo, California, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
12
Total Funding:
129000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-01-20
Last Funding Type:
Series B
Register and Claim Ownership